Current Opinion in Organ Transplantation This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Current Opinion in Organ Transplantation welcomes a new Editor-in-Chief
Curr Opin Organ Transplant. 2024 Feb 1;29(1):1-2. doi: 10.1097/MOT.0000000000001132. Epub 2024 Jan 4.NO ABSTRACTPMID:38164938 | DOI:10.1097/MOT.0000000000001132 (Source: Current Opinion in Organ Transplantation)
Source: Current Opinion in Organ Transplantation - January 2, 2024 Category: Transplant Surgery Authors: Sarah J Booth Source Type: research

Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy
Curr Opin Organ Transplant. 2023 Dec 27. doi: 10.1097/MOT.0000000000001133. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The increasing success of liver transplantation in hepatocellular carcinoma (HCC) drives an ever-evolving search for innovative strategies to broaden eligible patients' pools. Recent advances in immuno-oncology have turned the spotlight on immune checkpoint inhibitors (ICIs). This review offers an updated overview of ICIs in liver transplantation for HCC, exploring neoadjuvant and adjuvant approaches and addressing unanswered questions on safety, patients' selection, and response predictors.RECENT FI...
Source: Current Opinion in Organ Transplantation - January 2, 2024 Category: Transplant Surgery Authors: Parissa Tabrizian Marcus Zeitlhoefler Ahmed Talaat Hassan Rebecca Marino Source Type: research

Editorial introductions
Curr Opin Organ Transplant. 2024 Feb 1;29(1):v-vi. doi: 10.1097/MOT.0000000000001121. Epub 2024 Jan 4.NO ABSTRACTPMID:38164937 | DOI:10.1097/MOT.0000000000001121 (Source: Current Opinion in Organ Transplantation)
Source: Current Opinion in Organ Transplantation - January 2, 2024 Category: Transplant Surgery Source Type: research

Advances in desensitization for human leukocyte antigen incompatible kidney transplantation
Curr Opin Organ Transplant. 2023 Dec 14. doi: 10.1097/MOT.0000000000001131. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Human leukocyte antigen (HLA) sensitization is a major barrier to kidney transplantation induced by exposure to alloantigens through pregnancy, blood product exposure and previous transplantations. Desensitization strategies are undertaken to improve the chances of finding compatible organ offers. Standard approaches to desensitization include the use of plasmapheresis/low dose intravenous immunoglobulin (IVIG) or high dose IVIG plus anti-CD20. However, current methods to reduce HLA antibodies are no...
Source: Current Opinion in Organ Transplantation - December 13, 2023 Category: Transplant Surgery Authors: Ashley Vo Noriko Ammerman Stanley C Jordan Source Type: research